COVID-19 呼吸窘迫综合征的静脉-静脉体外膜肺氧合支持：初步经验。
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.
机构信息
From the Cardiac Surgery Unit, Cardio-Thorac-Vascular Department, S. Orsola Hospital, ALMA Mater Studiorum University of Bologna, Bologna, Italy.
Anaesthesiology and Intensive Care Unit, Cardio-Thorac-Vascular Department, S. Orsola Hospital, ALMA Mater Studiorum University of Bologna, Bologna, Italy.
出版信息
ASAIO J. 2020 Jul;66(7):734-738. doi: 10.1097/MAT.0000000000001198.
Abstract
SARS-CoV-2 may cause severe respiratory failure due to massive alveolar damage. Currently, no adequate curative therapy for Coronavirus Disease 2019 (COVID-19) disease exists. By considering overall impact of COVID-19 pandemic outbreak, an increased need of extracorporeal membrane oxygenation (ECMO) support becomes evident. We report on our preliminary institutional experience with COVID-19 patients receiving venovenous ECMO support.
摘要
SARS-CoV-2 可能会因大量肺泡损伤而导致严重呼吸衰竭。目前，针对 2019 年冠状病毒病（COVID-19）尚无有效的治疗方法。鉴于 COVID-19 大流行的全面影响，体外膜肺氧合（ECMO）支持的需求明显增加。我们报告了 COVID-19 患者接受静脉-静脉 ECMO 支持的初步机构经验。
相似文献
1
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.COVID-19 呼吸窘迫综合征的静脉-静脉体外膜肺氧合支持：初步经验。
ASAIO J. 2020 Jul;66(7):734-738. doi: 10.1097/MAT.0000000000001198.
2
Clinical feedback from experience with COVID-19: Specific considerations for extracorporeal membrane oxygenation.COVID-19临床经验反馈：体外膜肺氧合的特殊考量
J Infect. 2020 Sep;81(3):e59-e60. doi: 10.1016/j.jinf.2020.06.050. Epub 2020 Jun 21.
3
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
4
Extracorporeal membrane oxygenation and COVID-19: The causes of failure.体外膜肺氧合与新型冠状病毒肺炎：失败原因
J Card Surg. 2020 Oct;35(10):2838-2843. doi: 10.1111/jocs.14867. Epub 2020 Jul 17.
5
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?体外膜肺氧合用于治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征的重症患者：值得一试吗？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):460-463. doi: 10.1164/rccm.202004-1370LE.
6
Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic.COVID-19 大流行期间静脉-静脉体外膜肺氧合的特殊注意事项。
ASAIO J. 2020 Nov/Dec;66(10):1069-1072. doi: 10.1097/MAT.0000000000001251.
7
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
8
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.体外膜肺氧合治疗 2019 冠状病毒病所致急性呼吸窘迫综合征：一项多中心描述性研究。
Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
9
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients.体外膜肺氧合治疗 2019 年冠状病毒病所致严重肺和心功能障碍：32 例患者的经验。
ASAIO J. 2020 Jul;66(7):722-730. doi: 10.1097/MAT.0000000000001185.
10
Veno-venous extracorporeal membrane oxygenation for perioperative management of infective endocarditis after COVID-19 with acute respiratory distress syndrome: a case report.COVID-19 合并急性呼吸窘迫综合征患者感染性心内膜炎围手术期应用静脉-静脉体外膜肺氧合治疗：病例报告。
J Cardiothorac Surg. 2024 Jun 24;19(1):358. doi: 10.1186/s13019-024-02890-w.
引用本文的文献
1
Longer Prehospitalization and Preintubation Periods in Intubated Non-survivors and ECMO Patients With COVID-19: A Systematic Review and Meta-Analysis.COVID-19插管非幸存者和体外膜肺氧合（ECMO）患者的院前和插管前期更长：一项系统评价和荟萃分析
Front Med (Lausanne). 2021 Oct 15;8:727101. doi: 10.3389/fmed.2021.727101. eCollection 2021.
2
Extracorporeal Membrane Oxygenation Used in Acute Respiratory Distress Syndrome with COVID-19: A Systematic Review and Meta-Analysis.体外膜肺氧合用于新型冠状病毒肺炎所致急性呼吸窘迫综合征：一项系统评价与Meta分析
J Saudi Heart Assoc. 2021 Jul 2;33(2):177-185. doi: 10.37616/2212-5043.1261. eCollection 2021.
3
Checklists Improve Team Performance During Simulated Extracorporeal Membrane Oxygenation Emergencies: A Randomized Trial.检查表可提高体外膜肺氧合模拟紧急情况期间的团队绩效：一项随机试验。
Crit Care Explor. 2021 Apr 26;3(4):e0404. doi: 10.1097/CCE.0000000000000404. eCollection 2021 Apr.
4
Extracorporeal Membrane Oxygenation in Patients With COVID-19: An International Multicenter Cohort Study.COVID-19患者的体外膜肺氧合：一项国际多中心队列研究
J Intensive Care Med. 2021 Aug;36(8):910-917. doi: 10.1177/08850666211007063. Epub 2021 Apr 7.
5
Mechanical circulatory support in coronavirus disease-2019-positive patients with severe respiratory failure.COVID-19 阳性重症呼吸衰竭患者的机械循环支持。
Interact Cardiovasc Thorac Surg. 2021 Aug 18;33(3):489-493. doi: 10.1093/icvts/ivab087.
6
Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation.COVID-19 患者行静脉-静脉体外膜肺氧合的死亡率评估。
Ann Thorac Surg. 2021 Dec;112(6):1983-1989. doi: 10.1016/j.athoracsur.2020.12.050. Epub 2021 Jan 21.
7
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?体外膜肺氧合在2019冠状病毒病患者中的应用：证据是否充分？
J Cardiothorac Vasc Anesth. 2021 Apr;35(4):1256-1262. doi: 10.1053/j.jvca.2020.07.070. Epub 2020 Jul 30.
本文引用的文献
1
Turkish Society of Cardiovascular Surgery (TSCVS) Proposal for use of ECMO in respiratory and circulatory failure in COVID-19 pandemic era.土耳其心血管外科学会（TSCVS）关于在COVID-19大流行时代将体外膜肺氧合（ECMO）用于呼吸和循环衰竭的建议。
Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Mar 30;28(2):229-235. doi: 10.5606/tgkdc.dergisi.2020.09293. eCollection 2019 Jun.
2
Clinical Characteristics of Covid-19 in China. Reply.中国新冠病毒肺炎的临床特征。回复
N Engl J Med. 2020 May 7;382(19):1861-1862. doi: 10.1056/NEJMc2005203. Epub 2020 Mar 27.
3
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.COVID-19 大流行期间和其他新发传染病疫情中严重急性呼吸窘迫综合征的体外膜肺氧合服务规划和供应。
Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20.
4
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
5
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
6
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
Zotero 插件